bioRxivMicrobiologyPreprint
Effects of fructooligosaccharides and Saccharomyces boulardii on the compositional structure and metabolism of gut microbiota in students
H. Fu, Z. Chen, W. Teng, Z. Du, Y. Zhang, X. Ye, Z. Yu, Y. Zhang, X. Pi
Abstract
Fructooligosaccharides (FOS) are a common prebiotic widely used in functional foods. Meanwhile, Saccharomyces boulardii is a fungal probiotic frequenly used in the clinical treatment of diarrhea. Compared with single use, the combination of prebiotics and probiotics may be more effective in regulating gut microbiota. Hence, the combined use of prebiotics and probiotics has become a hot spot in synbiotics research in recent years. The present study aimed to investigate the effects of FOS and S. boulardii-- alone or in combination--on the structure and metabolism of the gut microbiota in healthy primary and secondary school students using an in vitro fermentation model. The results indicated that S. boulardii alone could not effectively regulate the community structure and metabolism of the microbiota. However, both FOS and the combination of FOS and S. boulardii could effectively regulate the microbiota, significantly inhibiting the growth of Escherichia-Shigella and Bacteroides, and controlling the production of the gases including H2S and NH3. In addition, both FOS and the combination could significantly promote the growth of Bifidobacteria and Lactobacillus, lower environmental pH, and enhance several physiological functions related to synthesis and metabolism. Nevertheless, the combination had more unique benefits as it promoted the growth of Lactobacillus, significantly increased CO2 production and enhanced the functional pathways of carbon metabolism and pyruvic acid metabolism. These findings provide guidance for clinical application and a theoretical basis for the development of synbiotic preparations.
- organism: human
- assay: metagenomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- 2'-Fucosyllactose helps butyrate producers outgrow competitors in infant gut microbiota simulations
David M. Versluis, Ruud Schoemaker, … Roeland M. H. Merks·iSciencePeer-reviewed·Feb 3, 2024
- Identification of novel fructo-oligosaccharide bacterial consumers by pulse metatranscriptomics in a human stool sample
Catherine Prattico, Emmanuel Gonzalez, … Bastien Castagner·mSpherePeer-reviewed·Dec 19, 2024
- Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers
T. M. Schmidt, N. T. Baxter, … K. Kim·bioRxiv·Dec 6, 2018
- Botanicals impact the bifidogenic effect and metabolic outputs of in vitro fiber fermentation by gut-derived microbiota in individual-specific ways
D. G. Deemer, N. Voreades, … S. R. Lindemann·bioRxiv·Apr 17, 2023
- Tibicos differentially affects faecal microbiota composition and short-chain fatty acid production in prediabetic and healthy adults in a simulated digestive tract
Miin Chan, Xinwei Ruan, … Kate S. Howell·bioRxiv·Mar 26, 2025
- Fu Ling (Wolfiporia cocos) Fungal β-Glucan in Combination with Bacillus coagulans Improve Colitis-Related Outcomes and Cecal Fermentation in DSS-Treated Mice
Ka Lee, Nelson Kei, … Peter Chi Keung Cheung·bioRxiv·Oct 8, 2026